f | { | f | { |
| "author": "", | | "author": "", |
| "author_email": "", | | "author_email": "", |
| "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", |
| "groups": [ | | "groups": [ |
| { | | { |
| "description": "Group for publications", | | "description": "Group for publications", |
| "display_name": "Publication", | | "display_name": "Publication", |
| "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", |
| "image_display_url": | | "image_display_url": |
| mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", |
| "name": "publication", | | "name": "publication", |
| "title": "Publication" | | "title": "Publication" |
| } | | } |
| ], | | ], |
| "id": "4ac55119-d6d5-4db5-8ba5-0fffa3a14a06", | | "id": "4ac55119-d6d5-4db5-8ba5-0fffa3a14a06", |
| "isopen": false, | | "isopen": false, |
| "license_id": "notspecified", | | "license_id": "notspecified", |
| "license_title": "License not specified", | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2021-09-16T08:12:09.627689", | | "metadata_created": "2021-09-16T08:12:09.627689", |
n | "metadata_modified": "2022-04-28T09:20:58.828079", | n | "metadata_modified": "2022-04-28T09:22:00.515130", |
| "name": "malawi-integrated-hiv-program-report-2017-q1", | | "name": "malawi-integrated-hiv-program-report-2017-q1", |
| "notes": "* Scale-up of integrated HIV services had reached the | | "notes": "* Scale-up of integrated HIV services had reached the |
| following number of sites:\r\n * __751__ static and 225 outreach | | following number of sites:\r\n * __751__ static and 225 outreach |
| HIV testing sites\r\n * __722__ (static) ART sites; 628 of these | | HIV testing sites\r\n * __722__ (static) ART sites; 628 of these |
| started at least one pregnant or breastfeeding woman and 691 started | | started at least one pregnant or breastfeeding woman and 691 started |
t | asymptomatic patients (Test & Treat) this quarter\r\n* __656__ sites | t | asymptomatic patients (Test & Treat) this quarter\r\n * __656__ |
| with HIV-exposed children in follow-up.\r\n\r\n* __982,561__ persons | | sites with HIV-exposed children in follow-up.\r\n\r\n* __982,561__ |
| were tested for HIV and received their results; __265,734 | | persons were tested for HIV and received their results; __265,734 |
| (27%)__\r\naccessed HIV testing for the first time; __716,827 (73 %)__ | | (27%)__\r\naccessed HIV testing for the first time; __716,827 (73 %)__ |
| were repeat testers and __46,822 (7%)__ of these received confirmatory | | were repeat testers and __46,822 (7%)__ of these received confirmatory |
| testing (after having tested positive in the past). __41,113 (4%)__ | | testing (after having tested positive in the past). __41,113 (4%)__ |
| clients received a positive result for the first time.\r\n\r\n* | | clients received a positive result for the first time.\r\n\r\n* |
| __24,024 (99%)__ of __24,329__ blood units collected were screened for | | __24,024 (99%)__ of __24,329__ blood units collected were screened for |
| (at least) HIV,\r\nhepatitis B and syphilis.\r\n\r\n* __151,227 | | (at least) HIV,\r\nhepatitis B and syphilis.\r\n\r\n* __151,227 |
| (97%)__ of __155,519__ women at ANC had their HIV status ascertained; | | (97%)__ of __155,519__ women at ANC had their HIV status ascertained; |
| __11,460 (8%)__ of these were HIV positive. __128,374 (99%)__ of | | __11,460 (8%)__ of these were HIV positive. __128,374 (99%)__ of |
| __134,140__ women at maternity had their HIV status ascertained 9,654 | | __134,140__ women at maternity had their HIV status ascertained 9,654 |
| (8%) of these were HIV positive.\r\n\r\n* __35,762__ patients started | | (8%) of these were HIV positive.\r\n\r\n* __35,762__ patients started |
| ART this quarter; 75% of these were classified as asymptomatic / in | | ART this quarter; 75% of these were classified as asymptomatic / in |
| WHO stage 1 and started under the new \u201cTest & Treat\u201d | | WHO stage 1 and started under the new \u201cTest & Treat\u201d |
| policy.\r\n\r\n* __691,314__ patients were alive and on ART by end of | | policy.\r\n\r\n* __691,314__ patients were alive and on ART by end of |
| March 2017. This means that 67% of the estimated __1,033,000__ HIV | | March 2017. This means that 67% of the estimated __1,033,000__ HIV |
| positive population was on ART. ART coverage was __54% (54,119 / | | positive population was on ART. ART coverage was __54% (54,119 / |
| 101,000)__ for children and __68% (637,195 / 932,000)__ for | | 101,000)__ for children and __68% (637,195 / 932,000)__ for |
| adults.\r\n\r\n* __54,868 (87%) of 62,845__ viral load results from | | adults.\r\n\r\n* __54,868 (87%) of 62,845__ viral load results from |
| routine monitoring were <1000 copies/ml. Viral suppression rates among | | routine monitoring were <1000 copies/ml. Viral suppression rates among |
| children (0-14 years) and adults (15+years) were 61% and 90%, | | children (0-14 years) and adults (15+years) were 61% and 90%, |
| respectively.\r\n\r\n* __75%__ of adults and __78%__ of children were | | respectively.\r\n\r\n* __75%__ of adults and __78%__ of children were |
| retained alive on ART at 12 months after initiation. Actual retention | | retained alive on ART at 12 months after initiation. Actual retention |
| rates are thought to be about 10% higher due to misclassification of | | rates are thought to be about 10% higher due to misclassification of |
| \u2018silent transfers\u2019 as defaulters in clinic-based | | \u2018silent transfers\u2019 as defaulters in clinic-based |
| survival/retention analysis. (see section 15.4)\r\n\r\n* __603,734 | | survival/retention analysis. (see section 15.4)\r\n\r\n* __603,734 |
| (93%) of 677,441__ patients on first line adult ART were on | | (93%) of 677,441__ patients on first line adult ART were on |
| TDF/3TC/EFV.\r\n\r\n* __12,323 3 (93%)__ of an estimated __13,250__ | | TDF/3TC/EFV.\r\n\r\n* __12,323 3 (93%)__ of an estimated __13,250__ |
| HIV infected pregnant women in Malawi were on ART this quarter. | | HIV infected pregnant women in Malawi were on ART this quarter. |
| __7,795 (63%)__ of these were already on ART when getting pregnant and | | __7,795 (63%)__ of these were already on ART when getting pregnant and |
| __4,528 (37%)__ started ART during pregnancy/delivery.\r\n\r\n* An | | __4,528 (37%)__ started ART during pregnancy/delivery.\r\n\r\n* An |
| additional __1,464__ breastfeeding women started ART in WHO stage 1 or | | additional __1,464__ breastfeeding women started ART in WHO stage 1 or |
| 2.\r\n\r\n* __79%, 73%, 67% and 65%__ of women started while pregnant | | 2.\r\n\r\n* __79%, 73%, 67% and 65%__ of women started while pregnant |
| or breastfeeding were retained on ART at 6, 12, 24 and 36 months after | | or breastfeeding were retained on ART at 6, 12, 24 and 36 months after |
| initiation, respectively.\r\n\r\n* __9,128 (7%)__ of infants | | initiation, respectively.\r\n\r\n* __9,128 (7%)__ of infants |
| discharged alive from maternity were known to be HIV exposed, __8,674 | | discharged alive from maternity were known to be HIV exposed, __8,674 |
| (95%)__ of these received ARV prophylaxis (nevirapine). __10,007__ | | (95%)__ of these received ARV prophylaxis (nevirapine). __10,007__ |
| were enrolled in exposed child follow-up before age 2 months.\r\n\r\n* | | were enrolled in exposed child follow-up before age 2 months.\r\n\r\n* |
| A total of __13,606__ HIV exposed children were newly enrolled for | | A total of __13,606__ HIV exposed children were newly enrolled for |
| follow-up this\r\nquarter.", | | follow-up this\r\nquarter.", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 1, | | "num_tags": 1, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
| "description": "The Department of HIV & AIDS (DHA) was established | | "description": "The Department of HIV & AIDS (DHA) was established |
| in 2001, initially as a unit in the Department of Clinical Services, | | in 2001, initially as a unit in the Department of Clinical Services, |
| to coordinate the biomedical HIV Program in Malawi. The department now | | to coordinate the biomedical HIV Program in Malawi. The department now |
| carries responsibility for various HIV related programs including: | | carries responsibility for various HIV related programs including: |
| sexually transmitted infections (STIs), prevention of mother to child | | sexually transmitted infections (STIs), prevention of mother to child |
| transmission of HIV (PMTCT), and national voluntary male medical | | transmission of HIV (PMTCT), and national voluntary male medical |
| circumcision program (VMMC). All these HIV program sub-sections are | | circumcision program (VMMC). All these HIV program sub-sections are |
| linked to one robust monitoring and evaluation sub-section in the HIV | | linked to one robust monitoring and evaluation sub-section in the HIV |
| and AIDS Department which technically operates under the Central | | and AIDS Department which technically operates under the Central |
| Monitoring and Evaluation Department (CMED) of the Ministry of | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| Health.", | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "image_url": | | "image_url": |
| 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
| "title": "Department of HIV & AIDS and Viral Hepatitis", | | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2022-03-23T19:57:02.350823", | | "created": "2022-03-23T19:57:02.350823", |
| "description": "", | | "description": "", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "1596c407-65a0-4ce8-9603-78957abbb494", | | "id": "1596c407-65a0-4ce8-9603-78957abbb494", |
| "last_modified": "2022-04-04T13:51:08.741405", | | "last_modified": "2022-04-04T13:51:08.741405", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2017-q1", | | "dha/malawi-integrated-hiv-program-report-2017-q1", |
| "metadata_modified": "2022-04-04T13:51:08.761238", | | "metadata_modified": "2022-04-04T13:51:08.761238", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "malawi-integrated-hiv-program-report-2017-q1", | | "name": "malawi-integrated-hiv-program-report-2017-q1", |
| "package_id": "4ac55119-d6d5-4db5-8ba5-0fffa3a14a06", | | "package_id": "4ac55119-d6d5-4db5-8ba5-0fffa3a14a06", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "ebfa7735789a6d21029e1b77de322d187e002fba13133f984cd6284dc9c003f2", | | "ebfa7735789a6d21029e1b77de322d187e002fba13133f984cd6284dc9c003f2", |
| "size": 4277954, | | "size": 4277954, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| 957abbb494/download/malawi-integrated-hiv-program-report-2017-q1.pdf", | | 957abbb494/download/malawi-integrated-hiv-program-report-2017-q1.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "Report", | | "display_name": "Report", |
| "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", |
| "name": "Report", | | "name": "Report", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2017 Q1", | | "title": "Malawi Integrated HIV Program Report 2017 Q1", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2017" | | "year": "2017" |
| } | | } |